Pharma Equity Group A Aktie - 0REU

Pharma Equity Group A (0REU) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,40

( - )

Gebot

0,40

Fragen

0,40

Volumen

0,00

0,00 Tagesbereich 0,00

0,40 52-Wochen-Bereich 0,40

Handelsende

0,40

Handelsbeginn

Letzte Trade

(O)

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

0,00

Finanzvolumen

VWAP

Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs

Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs 12 June...

Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant

Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant Pharma Equity...

The Board of Directors' resolution on the issuance of convertible loans

The Board of Directors' resolution on the issuance of convertible loans The Board of Directors' resolution on the issuance of convertible...

Proceedings of the Annual General Meeting of Pharma Equity Group A/S

Proceedings of the Annual General Meeting of Pharma Equity Group A/S Proceedings of the Annual General Meeting of Pharma Equity Group A/S 17...

Notice convening the annual general meeting in Pharma Equity Group A/S

Notice convening the annual general meeting in Pharma Equity Group A/S 25 March 2026 Announcement no. 4 Notice convening the annual general...

Pharma Equity Group A/S - Annual Report 2025

Pharma Equity Group A/S - Annual Report 2025 25 March 2026 Announcement no. 3 Pharma Equity Group A/S - Annual Report 2025 Pharma Equity Group...

UPDATE OF THE FINANCIAL CALENDAR FOR 2026

UPDATE OF THE FINANCIAL CALENDAR FOR 2026 UPDATE OF THE FINANCIAL CALENDAR FOR 2026 Hørsholm 18 March 2026 Company announcement no 2 Pharma...

SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025

SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025 SUPPLEMENTARY INFORMATION...

2026 Financial Calendar

2026 Financial Calendar 3 February 2026 News Release Pharma Equity Group2026 Financial Calendar March 4Deadline for shareholder proposals...

Pharma Equity Group – Strategic update and adjustment of expectations

Pharma Equity Group – Strategic update and adjustment of expectations Pharma Equity Group – Strategic update and adjustment of expectations...

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0.4	0.4	0.4	0	0	DE
52	0.4	0.4	0.4	767	0.4	DE
156	0.4	0.4	0.4	200	0.4	DE
260	0.4	0.4	0.4	115	0.4	DE

0REU - Frequently Asked Questions (FAQ)

What is the current Pharma Equity Group A share price?

The current share price of Pharma Equity Group A is kr 0,40

What is the 1 year trading range for Pharma Equity Group A share price?

Pharma Equity Group A has traded in the range of kr 0,40 to kr 0,40 during the past year

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0.4	0.4	0.4	0	0	DE
52	0.4	0.4	0.4	767	0.4	DE
156	0.4	0.4	0.4	200	0.4	DE
260	0.4	0.4	0.4	115	0.4	DE

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0.4	0.4	0.4	0	0	DE
52	0.4	0.4	0.4	767	0.4	DE
156	0.4	0.4	0.4	200	0.4	DE
260	0.4	0.4	0.4	115	0.4	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharma Equity Group A (0REU)

Pharma Equity Group A (0REU) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

0REU Neueste Nachrichten

Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs

Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant

The Board of Directors' resolution on the issuance of convertible loans

Proceedings of the Annual General Meeting of Pharma Equity Group A/S

Notice convening the annual general meeting in Pharma Equity Group A/S

Pharma Equity Group A/S - Annual Report 2025

UPDATE OF THE FINANCIAL CALENDAR FOR 2026

SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025

2026 Financial Calendar

Pharma Equity Group – Strategic update and adjustment of expectations

Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs

Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant

The Board of Directors' resolution on the issuance of convertible loans

Proceedings of the Annual General Meeting of Pharma Equity Group A/S

Notice convening the annual general meeting in Pharma Equity Group A/S

Pharma Equity Group A/S - Annual Report 2025

UPDATE OF THE FINANCIAL CALENDAR FOR 2026

SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025

2026 Financial Calendar

Pharma Equity Group – Strategic update and adjustment of expectations

Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S

Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026

0REU - Frequently Asked Questions (FAQ)

0REU Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen

Zeitraum †	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0.4	0.4	0.4	0	0	DE
52	0.4	0.4	0.4	767	0.4	DE
156	0.4	0.4	0.4	200	0.4	DE
260	0.4	0.4	0.4	115	0.4	DE